Cancers 2010, 2(2), 1312-1327; doi:10.3390/cancers2021312

Serum Biomarkers for Early Detection of Gynecologic Cancers

email, * email, email, email, email, email and email
Received: 8 March 2010; in revised form: 31 May 2010 / Accepted: 3 June 2010 / Published: 14 June 2010
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Ovarian, endometrial, and cervical cancers are three of the most common malignancies of the female reproductive organs. CA 125, historically the most reliable serum marker for ovarian cancer, is elevated in 50% of early-stage ovarian tumors. For endometrial cancers, there are no established serum markers. SCC, which is the best studied serum marker for squamous cell carcinomas, has been unreliable; SCC is elevated in cervical squamous cell carcinomas ranging from 28–85% of the time. Recent proteomics-based analyses show great promise for the discovery of new and more useful biomarkers. In this review, we will discuss the currently utilized serum tumor markers for gynecologic cancers and the novel biomarkers that are now under investigation.
Keywords: ovarian; endometrial; cervical; cancer; serum; tumor marker; CA 125; SCC; proteomics; biomarkers
PDF Full-text Download PDF Full-Text [353 KB, uploaded 14 June 2010 10:12 CEST]

Export to BibTeX |

MDPI and ACS Style

Ueda, Y.; Enomoto, T.; Kimura, T.; Miyatake, T.; Yoshino, K.; Fujita, M.; Kimura, T. Serum Biomarkers for Early Detection of Gynecologic Cancers. Cancers 2010, 2, 1312-1327.

AMA Style

Ueda Y, Enomoto T, Kimura T, Miyatake T, Yoshino K, Fujita M, Kimura T. Serum Biomarkers for Early Detection of Gynecologic Cancers. Cancers. 2010; 2(2):1312-1327.

Chicago/Turabian Style

Ueda, Yutaka; Enomoto, Takayuki; Kimura, Toshihiro; Miyatake, Takashi; Yoshino, Kiyoshi; Fujita, Masami; Kimura, Tadashi. 2010. "Serum Biomarkers for Early Detection of Gynecologic Cancers." Cancers 2, no. 2: 1312-1327.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert